These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3583485)

  • 1. Dose-dependent shortening of systolic time intervals after intake of pengitoxin.
    Haustein KO; Hentschel H
    Int J Clin Pharmacol Res; 1987; 7(1):19-25. PubMed ID: 3583485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraordinary efficacy of 16 alpha-gitoxin, an ultra-short acting semi-synthetic digitalis glycoside.
    Haustein KO; Bauer R
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):299-304. PubMed ID: 7921531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of pengitoxin and its therapeutic efficacy in congestive heart failure.
    Haustein KO; Wesser M
    Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):8-15. PubMed ID: 3403092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A correlation between digoxin plasma concentrations and systolic time intervals in hospitalized congestive heart failure patients.
    Vemuri S; Barr WH; Propert DB
    Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):388-93. PubMed ID: 1446955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac effects of 16-acetyl-gitoxin, the active glycoside after penta-acetyl-gitoxin administration.
    Haustein KO; Hauptmann J; Nowak G
    Acta Biol Med Ger; 1978; 37(11-12):1713-20. PubMed ID: 754425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of systolic left ventricular time interval using the doppler technique. Analysis of aortic flow spectrum with transthoracic echocardiography].
    Menzel T; Mohr-Kahaly S; Epperlein S; Fischer K; Wittlich N; Nixdorff U; Meyer J
    Arzneimittelforschung; 1996 Feb; 46(2):228-34. PubMed ID: 8720321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic and cardiac efficacy of beta-acetyldigoxin and digitoxin in combination therapy with diltiazem].
    Kuhlmann J; Marcin S
    Klin Wochenschr; 1985 Jul; 63(14):636-42. PubMed ID: 4032988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems of an optimum digitalis therapy.
    Haustein KO; Hentschel H; Kaiser B
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):352-6. PubMed ID: 7409938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac effects of a single daily dose of 0.15 mg and 0.20 mg of beta-methyldigoxin].
    Belz GG; Wintrich R
    Z Kardiol; 1984 Jan; 73(1):29-33. PubMed ID: 6367246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum levels of beta-methyldigoxin and contractile efficiency of the myocardium evaluated with systolic polygraphy and determination of cardiac output].
    Pelosi G; Bracchi G; Orazio S; Cereda A
    Minerva Med; 1981 Feb; 72(4-5):225-31. PubMed ID: 7010220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive assessment of left ventricular function related to serum digoxin levels in neonates.
    Sandor GG; Bloom KR; Izukawa T; Patterson MW; Rowe RD
    Pediatrics; 1980 Mar; 65(3):541-6. PubMed ID: 7360542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
    Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
    J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the pharmacokinetics of pengitoxin and its cardioactive derivative 16-acetyl-gitoxin.
    Haustein KO; Alken RG; Lach HJ; Becker U; Rietbrock N
    Eur J Clin Pharmacol; 1983; 25(3):369-73. PubMed ID: 6628525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic time intervals and the QT-QS2 interval in young female diabetics.
    Airaksinen J; Ikäheimo M; Kaila J; Linnaluoto M; Takkunen J
    Ann Clin Res; 1984; 16(4):188-91. PubMed ID: 6508220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in color vision impairment caused by digoxin, digitoxin, or pengitoxin.
    Haustein KO; Oltmanns G; Rietbrock N; Alken RG
    J Cardiovasc Pharmacol; 1982; 4(4):536-41. PubMed ID: 6181326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systolic time intervals during isometric exercise in supine position should be corrected also for arterial pressure.
    Cinelli P; De Leonardis V; Buffoni M; Mori F
    Acta Cardiol; 1982; 37(2):93-103. PubMed ID: 6980553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of blood pressure and systolic time intervals by diuretics and beta-blockers in essential hypertension.
    González-Gómez A; Gamio Capestany F; Hernández-Cañero A; García-Barreto D
    Cor Vasa; 1983; 25(4):233-40. PubMed ID: 6139268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the pharmacokinetics of 16-acetyl-gitoxin and its bioavailability from pengitoxin-containing tablet formulations.
    Haustein KO
    J Pharmacokinet Biopharm; 1986 Aug; 14(4):357-64. PubMed ID: 3772737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of orthostatic stress on systolic time intervals in rabbits.
    Singh K
    Indian J Physiol Pharmacol; 2004 Jul; 48(3):361-4. PubMed ID: 15648411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.